1. Aaronson NK, Cull AM, Kaasa S, Sprangers MAG (1996) The European Organization for Research and Treatment of Cancer (EORTC) Modular Approach to Quality of Life Assessment in Oncology: An Update. In: Spilker B (Hrsg) Quality of Life and Pharmaeconomics in Clinical Trials. Lippincott-Raven, Philadelphia, S 179–190
2. Ahmed S, Berzon R a, Revicki D a, et al. The use of patient-reported outcomes (PRO) within comparative effectiveness research: implications for clinical practice and health care policy. Med. Care. 2012;50(12):1060–1070.
3. Anderson RT, Aaronson NK, Leplège AP Wilkin D (1996) International Use and Application of Generic Health-Related Quality of Life Instruments. In: Spilker B. (Hrsg) Quality of Life and Pharmaeconomics in Clinical Trials. Lipincott- Raven, Philadelphia, S 613–632
4. Bergner M, Bobbit RA, Carter WB, Gilson BS (1981) The Sickness Impact Profile: Development and Final Revision of a Health Status Measure. Medical Care 19:780–805
5. Bowling A, (1991) Measuring Health: A Review of Quality of Life Measurement Scales. Milton Keynes, Philadelphia Open University Press